| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/31/2001 | CA2392375A1 Synthetic oligomannosides, preparation and uses thereof |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392365A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 05/31/2001 | CA2392356A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 05/31/2001 | CA2392272A1 Modified adenovirus fibre and uses |
| 05/31/2001 | CA2392235A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 05/31/2001 | CA2392225A1 Novel il-8 receptor antagonists |
| 05/31/2001 | CA2391943A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 05/31/2001 | CA2391145A1 Method of preparing clarithromycin |
| 05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | CA2390724A1 Combination of fluazuron and invermectin for parasite control |
| 05/31/2001 | CA2390344A1 85kda neisserial antigen |
| 05/31/2001 | CA2389667A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/31/2001 | CA2389568A1 Osmotic dosage form comprising first and second coats |
| 05/31/2001 | CA2387591A1 Use of indirubine derivatives for making medicines |
| 05/31/2001 | CA2387575A1 Coating |
| 05/31/2001 | CA2386955A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/31/2001 | CA2386893A1 N-alkylated peptides having antiangiogenic activity |
| 05/30/2001 | EP1103615A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103610A1 Production of vaccines from immortalised mammalian cell lines |
| 05/30/2001 | EP1103252A1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 05/30/2001 | EP1103181A1 Combination of N-phenyl-N'-benzoyl urea derivatives and avermectine compounds for parasite control |
| 05/30/2001 | EP1102848A2 Molecules designated ldcam |
| 05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 05/30/2001 | EP1102789A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 05/30/2001 | EP1102788A2 Prevention and treatment of viral disease |
| 05/30/2001 | EP1102787A1 2'-o-aminoethyloxyethyl-modified oligonucleotides |
| 05/30/2001 | EP1102761A2 Cyclopentabenzofuran derivatives and their use |
| 05/30/2001 | EP1102743A1 Amide derivatives which are useful as cytokine inhibitors |
| 05/30/2001 | EP1102596A1 Peptide antagonists of zonulin and methods for use of the same |
| 05/30/2001 | EP1102535A2 Compounds and methods |
| 05/30/2001 | EP1032265A4 New psoralens for pathogen inactivation |
| 05/30/2001 | EP0752992B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 05/30/2001 | EP0687176B1 Use of riluzole for treating aids-related neural disorders |
| 05/30/2001 | EP0660712B1 Transcutaneous in vivo activation of photosensitive agents in blood |
| 05/30/2001 | EP0658109B1 Metallo porphyrin compositions |
| 05/30/2001 | EP0656778B1 Enantiomerically pure beta-d-dioxolane-nucleosides |
| 05/30/2001 | EP0621788B1 Hemoregulatory peptides |
| 05/30/2001 | CN1297486A Anti-viral vectors |
| 05/30/2001 | CN1297482A Group B streptococcus antigens |
| 05/30/2001 | CN1297455A Composition and pharmaceutical preparation contg. same for treatment of herpes and related viral infections |
| 05/30/2001 | CN1297447A Anti-viral pyrimidine derivs |
| 05/30/2001 | CN1297437A Substd. 2-oxo-alkanoic acid-[2-(indol-3-yl)-ethyl] amides |
| 05/30/2001 | CN1297356A Matrix protein compositions for wound healing |
| 05/30/2001 | CN1297355A Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 05/30/2001 | CN1297352A Use of organophosphoric compounds for therapeutic and preventative treatment of infections |
| 05/30/2001 | CN1296953A Mycoplasma hyopnaumoniae (mhp) 3 gene nuclein and protein, and use thereof |
| 05/30/2001 | CN1296845A Capsule 'Feidanwang' for treating pulmonary tuberculosis |
| 05/30/2001 | CN1296843A Capsule 'Lifeiqing' for treating pulmonary tuberculosis |
| 05/30/2001 | CN1296840A Teng tea as beverage |
| 05/30/2001 | CN1296839A Process and formulation for preparing bezoar mux vomica powder medicine 'Kuangquanling' and its product |
| 05/30/2001 | CN1296822A Medicine for treating pulmonary tuberculosis |
| 05/30/2001 | CN1296804A Process for preparing recombined heterobone with strong anti-infection power |
| 05/30/2001 | CN1066456C Oligonucleotides having 2'-ether groups |
| 05/30/2001 | CN1066452C Crystalline cephem acid addition salts and processes for their preparation |
| 05/30/2001 | CN1066447C Imidazo [4,5-c] quinoline amines |
| 05/30/2001 | CN1066329C Preparation of drug composition |
| 05/29/2001 | US6239296 Process for a phenylthiobutyl-isoquinoline and intermediates therefor |
| 05/29/2001 | US6239288 Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis |
| 05/29/2001 | US6239283 Bactericides; reacting 4-one-tetrahydrothiopyran |
| 05/29/2001 | US6239265 Oligonucleotides having chiral phosphorus linkages |
| 05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 05/29/2001 | US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents |
| 05/29/2001 | US6239152 Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| 05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
| 05/29/2001 | US6239142 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5carboxamides as antiviral agents |
| 05/29/2001 | US6239141 Antibiotic |
| 05/29/2001 | US6239125 Antiviral agents against herpes viruses. |
| 05/29/2001 | US6239123 Use of estrogenic compounds as anti-fungal agents |
| 05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
| 05/29/2001 | US6239113 Topical treatment or prevention of ocular infections |
| 05/29/2001 | US6239112 Water miscible macrolide solutions |
| 05/29/2001 | US6239106 Family of protease inhibitors, and other biologic active substances |
| 05/29/2001 | US6239102 Concentrate comprising, as active agent, (3'-desoxy-3-oxo-mebmc)1-(val)2-cyclosporin, stabilizer selected from oleic acid or palmitoyl oleoyl phosphatidyl glycerol or salts thereof, ethanol |
| 05/29/2001 | US6238914 Nucleic acid |
| 05/29/2001 | US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides |
| 05/29/2001 | US6238887 Ribosome recycling factor (FRR) of Staphylococcus aureus |
| 05/29/2001 | US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines |
| 05/29/2001 | US6238878 FVlla/TF activity inhibiting compounds |
| 05/29/2001 | US6238859 Virus protein antigens of the JC virus |
| 05/29/2001 | US6238695 Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 05/29/2001 | US6238683 Drug delivery |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | US6238666 Polypeptide |
| 05/29/2001 | US6238661 Use of bacterial phage associated lysing enzymes for treating various illnesses |
| 05/29/2001 | US6238659 Administering a compound influencing the cellular redox state which is a pyrrolidine dithiocarbamate or a derivative and a cytokine |
| 05/29/2001 | CA2171638C The semaphorin gene family |
| 05/29/2001 | CA2053339C Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines |
| 05/29/2001 | CA2031803C Improvements in or relating to glycopeptide deriveratives |
| 05/25/2001 | WO2001036641A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 05/25/2001 | WO2001036633A1 Novel protein and dna thereof |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 05/25/2001 | WO2001036625A2 ANTISENSE OLIGONUCLEOTIDE SEQUENCES DERIVED FROM groEL AND groES AS INHIBITORS MICROORGANISMS |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036599A1 Microparticle-based transfection and activation of dendritic cells |
| 05/25/2001 | WO2001036488A1 Antibody against the human toll-like receptor-2 (tlr2) and uses thereof |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036462A2 Protein c derivatives |
| 05/25/2001 | WO2001036454A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |